Position in IBRX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$168,096
+$118,966 QoQ
Shares Held
19,200
+3.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#237
of 401 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Derivatives in IBRX
reported options exposure · as of Jun 30, 2026CallValue
$17,510
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $9,749,803 across 5 Biotechnology names. IBRX ranks #4 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,049 | $4,494,909 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,458 | $3,148,171 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,005 | $1,873,737 | |
| 4 | IBRX |
ImmunityBio, Inc.
This page
|
19,200 | $168,096 | |
| 5 | NGEN |
Nervgen Pharma Corp.
|
31,500 | $64,890 |
All Filings in IBRX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $168,096 | 19,200 | Shares | Sole | 2026-07-22 | |
| 2026-06-30 | $17,510 | 2,000 | Call | Sole | 2026-07-22 | |
| 2025-06-30 | $49,130 | 18,610 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $96,621 | 32,100 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $16,640 | 6,500 | Call | Sole | 2025-01-17 | |
| 2024-12-31 | $80,896 | 31,600 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $61,008 | 16,400 | Call | Sole | 2024-10-25 | |
| 2024-09-30 | $113,422 | 30,490 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $194,024 | 30,700 | Shares | Sole | 2024-07-24 | |
| 2024-06-30 | $60,672 | 9,600 | Call | Sole | 2024-07-24 | |
| 2024-03-31 | $120,825 | 22,500 | Shares | Sole | 2024-04-12 | |
| 2024-03-31 | $21,480 | 4,000 | Call | Sole | 2024-04-12 | |
| 2023-12-31 | $85,591 | 17,050 | Shares | Sole | 2024-01-18 | |
| 2023-12-31 | $0 | 0 | Put | Sole | 2024-01-18 | |
| 2023-12-31 | $15,060 | 3,000 | Call | Sole | 2024-01-18 | |
| 2023-09-30 | $25,265 | 14,950 | Shares | Sole | 2023-10-16 | |
| No filing history on record for this holder in this stock. | ||||||